Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients...Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients. Nevertheless, few papers had been published studying the anxiety and depression scales in the treatment of CTS, either with corticosteroid injections (I) or with surgical decompression (S). Objective: To assess whether clinical improvement observed after the treatment of CTS either with I or with S correlates with an improvement in the punctuations of the Hospital Anxiety and Depression scales (HADS), at 3, 6 and 12-month follow-up. Methods: Randomized and open-label clinical trial, comparing I and S. Patients with symptoms suggestive of CTS (nocturnal paraesthesias) of at least 3 months duration and neurophysiological confirmation were included. Patients with clinically apparent motor impairment were excluded. The subjective evaluation of symptoms was carried out using the visual-analogue scale of pain (VAS-p). Clinical reviews were performed 3, 6 and 12 months after treatment. Each patient completed the HADS questionnaire and a VAS-p at 0, 3, 6, and 12 months. Statistical significance was established using the Student’s t test and the Mann-Whitney U test when necessary. A linear regression analysis was used to know the effect of the treatment adjusted for the initial score of both scales. Results: 65 patients were included (30 in group I and 35 in group S). There was no statistical difference between both groups in terms of age, gender distribution, disease duration, VAS-p, neurophysiological testing severity of CTS or the 8 subscales of HADS. Both groups improved significantly in relation to the baseline VAS-p values, in the reviews at 3, 6 and 12 months, with no significant differences between I and S. At 6 months, the reduction in the anxiety scale was around 3 points for both treatments (S = 3.6 and I = 3.2), without reaching significant differences. At 12 months, it was somewhat higher for those treated with I, but always around 3 points and without significant differences. The Depression scale score was slightly reduced at 6 months, and in a similar way for both groups (I = 1 and S = 1.19;p = 0.8). After 12 months, group I doubled the previous reduction, with group S experiencing a very slight change (I = 1.96 and S = 1.03;p = 0.3). When analysing the effect of group S on group I, the result was a reduction of 0.25 points for Anxiety (p = 0.7) and of 0.02 points for Depression (p = 0.9). Conclusions: Treatment of CTS with I or S results in a similar and discrete improvement in Anxiety scores on the HADS scale at 6 and 12 months. For both types of treatment, the Depression scores barely changed at 6 months, being somewhat higher in group I after 12-month follow-up. The independent effect of the S on both scales is small and not significant.展开更多
AIM:To determine the one-year outcomes of resveratrol oral supplement in patients suffering from wet age-related macular degeneration(AMD).METHODS:Fifty naïve and previously untreated patients suffering from wet ...AIM:To determine the one-year outcomes of resveratrol oral supplement in patients suffering from wet age-related macular degeneration(AMD).METHODS:Fifty naïve and previously untreated patients suffering from wet AMD,were randomly assigned in two subgroups of 25 patients each.All the participants were treated with 3 monthly intravitreal injections of 2.0 mg aflibercept(IAIs)followed by injections“according to need”,while in one group the patients also received daily two tablets of resveratrol oral supplement.Prior to treatment initiation,a complete ophthalmological examination,including best corrected visual acuity(BCVA)and contrast sensitivity evaluation,optical coherence tomography(OCT)scans,fundus autofluorescence(FAF),fluorescein angiography,indocyanine green angiography,and OCT angiography(OCTA),was performed to every participant,while all of them completed the Hospital Anxiety and Depression Scale(HADS)questionnaire,in order to assess their quality of life(QoL)status.The patients were assessed monthly for 1y with FAF,and OCT or OCTA;the main endpoints were the number IAIs,the changes in BCVA,in contrast sensitivity,and in patients’QoL status.RESULTS:No significant differences were present between the groups regarding the baseline demographic and clinical data.Over the 12-month period,a similar number of IAIs was applied in both groups(4.52±1.00 vs 4.28±0.90,P=0.38),while the rest of the clinical data also did not differ significantly after the completion of the study period.However,for HADS Depression(11.88±2.51 vs 8.28±1.54,P<0.001)and HADS Anxiety(11.92±2.52 vs 7.76±1.51,P<0.001)questionnaires values,the score was significantly better in patients who received resveratrol supplements.Moreover,a statistically significant difference was detected in the mean change from baseline values of contrast sensitivity(0.17±0.19 vs 0.35±0.24,P=0.005),HADS Depression(0.08±1.38 vs-3.88±1.48,P<0.001),and HADS Anxiety(0.36±1.98 vs-5.12±2.70,P<0.001)scores,in favour of the patients treated with resveratrol supplements.CONCLUSION:The resveratrol oral supplement is a complementary treatment in cases of wet AMD,highlighting its effectiveness in improving patients’QoL status.展开更多
目的观察无痛分娩联合音乐疗法对自然分娩产妇的影响。方法选择2022年1月至6月聊城市东昌府区妇幼保健院收治的88例拟行自然分娩的产妇进行随机对照试验。采用随机数字表法将其分为参照组与联合组,各44例。参照组年龄(30.56±1.06)...目的观察无痛分娩联合音乐疗法对自然分娩产妇的影响。方法选择2022年1月至6月聊城市东昌府区妇幼保健院收治的88例拟行自然分娩的产妇进行随机对照试验。采用随机数字表法将其分为参照组与联合组,各44例。参照组年龄(30.56±1.06)岁,初产30例,次产14例,孕周(39.18±0.48)周;联合组年龄(30.75±1.13)岁,初产31例,次产13例,孕周(39.25±0.54)周。对照组采用传统分娩方法,联合组在参照组的基础上接受音乐疗法治疗。对比两组产妇视觉模拟量表(VAS)评分、医院焦虑抑郁量表(HADS)评分、治疗过程中不良事件、转剖宫产的人数。采用t检验和χ^(2)检验。结果两组产后12 h VAS评分均较产后2 h降低(均P<0.05),且联合组产后12 h VAS评分低于参照组(P<0.05)。干预前,两组HADS评分比较,差异无统计学意义(P>0.05);产后,两组HADS评分均低于干预前(均P<0.05),且联合组HADS评分低于参照组(P<0.05)。参照组不良事件发生率为9.09%(4/44),联合组为11.36%(5/44),差异无统计学意义(P>0.05)。结论无痛分娩联合音乐疗法有利于缓解自然分娩产妇疼痛,可改善产妇负性情绪,且安全可靠,值得推广。展开更多
目的:在综合医院内科门诊病人中应用综合医院焦虑抑郁量表(Hospital Anxiety and Depres-sion Scale,HAD),并尝试建立上海地区常模。方法:采用两阶段抽样方法,首先在上海10余家综合医院中选取中山医院和瑞金医院内科门诊就诊人群,其次...目的:在综合医院内科门诊病人中应用综合医院焦虑抑郁量表(Hospital Anxiety and Depres-sion Scale,HAD),并尝试建立上海地区常模。方法:采用两阶段抽样方法,首先在上海10余家综合医院中选取中山医院和瑞金医院内科门诊就诊人群,其次按10∶1比例在连续就诊序列中随机抽取11766例患者,采用HAD自评或辅助询问评估。结果:(1)内科门诊各年龄组病人在HAD焦虑均分(F=12.518,P<0.001)和抑郁均分(F=28.066,P<0.001)上差异显著,即随年龄递增焦虑评分有所降低,而抑郁评分则有所增高。(2)女性的HAD焦虑评分高于男性[(3.37±2.81)vs.(3.14±2.62),P<0.001],HAD抑郁评分在总样本中差异无统计学意义;但在60岁以下样本中,女性抑郁评分高于男性[(3.67±3.01)vs.(3.39±2.91),P=0.038],而在60～69岁年龄段,男性抑郁总均分高于女性[(5.63±3.86)vs.(4.86±3.70),P<0.001]。结论:综合医院焦虑抑郁量表在内科门诊病人应用过程中需注意年龄和性别因素的影响。展开更多
文摘Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients. Nevertheless, few papers had been published studying the anxiety and depression scales in the treatment of CTS, either with corticosteroid injections (I) or with surgical decompression (S). Objective: To assess whether clinical improvement observed after the treatment of CTS either with I or with S correlates with an improvement in the punctuations of the Hospital Anxiety and Depression scales (HADS), at 3, 6 and 12-month follow-up. Methods: Randomized and open-label clinical trial, comparing I and S. Patients with symptoms suggestive of CTS (nocturnal paraesthesias) of at least 3 months duration and neurophysiological confirmation were included. Patients with clinically apparent motor impairment were excluded. The subjective evaluation of symptoms was carried out using the visual-analogue scale of pain (VAS-p). Clinical reviews were performed 3, 6 and 12 months after treatment. Each patient completed the HADS questionnaire and a VAS-p at 0, 3, 6, and 12 months. Statistical significance was established using the Student’s t test and the Mann-Whitney U test when necessary. A linear regression analysis was used to know the effect of the treatment adjusted for the initial score of both scales. Results: 65 patients were included (30 in group I and 35 in group S). There was no statistical difference between both groups in terms of age, gender distribution, disease duration, VAS-p, neurophysiological testing severity of CTS or the 8 subscales of HADS. Both groups improved significantly in relation to the baseline VAS-p values, in the reviews at 3, 6 and 12 months, with no significant differences between I and S. At 6 months, the reduction in the anxiety scale was around 3 points for both treatments (S = 3.6 and I = 3.2), without reaching significant differences. At 12 months, it was somewhat higher for those treated with I, but always around 3 points and without significant differences. The Depression scale score was slightly reduced at 6 months, and in a similar way for both groups (I = 1 and S = 1.19;p = 0.8). After 12 months, group I doubled the previous reduction, with group S experiencing a very slight change (I = 1.96 and S = 1.03;p = 0.3). When analysing the effect of group S on group I, the result was a reduction of 0.25 points for Anxiety (p = 0.7) and of 0.02 points for Depression (p = 0.9). Conclusions: Treatment of CTS with I or S results in a similar and discrete improvement in Anxiety scores on the HADS scale at 6 and 12 months. For both types of treatment, the Depression scores barely changed at 6 months, being somewhat higher in group I after 12-month follow-up. The independent effect of the S on both scales is small and not significant.
基金Supported by unrestricted Grant from Laboratoires Thea^(■),France.
文摘AIM:To determine the one-year outcomes of resveratrol oral supplement in patients suffering from wet age-related macular degeneration(AMD).METHODS:Fifty naïve and previously untreated patients suffering from wet AMD,were randomly assigned in two subgroups of 25 patients each.All the participants were treated with 3 monthly intravitreal injections of 2.0 mg aflibercept(IAIs)followed by injections“according to need”,while in one group the patients also received daily two tablets of resveratrol oral supplement.Prior to treatment initiation,a complete ophthalmological examination,including best corrected visual acuity(BCVA)and contrast sensitivity evaluation,optical coherence tomography(OCT)scans,fundus autofluorescence(FAF),fluorescein angiography,indocyanine green angiography,and OCT angiography(OCTA),was performed to every participant,while all of them completed the Hospital Anxiety and Depression Scale(HADS)questionnaire,in order to assess their quality of life(QoL)status.The patients were assessed monthly for 1y with FAF,and OCT or OCTA;the main endpoints were the number IAIs,the changes in BCVA,in contrast sensitivity,and in patients’QoL status.RESULTS:No significant differences were present between the groups regarding the baseline demographic and clinical data.Over the 12-month period,a similar number of IAIs was applied in both groups(4.52±1.00 vs 4.28±0.90,P=0.38),while the rest of the clinical data also did not differ significantly after the completion of the study period.However,for HADS Depression(11.88±2.51 vs 8.28±1.54,P<0.001)and HADS Anxiety(11.92±2.52 vs 7.76±1.51,P<0.001)questionnaires values,the score was significantly better in patients who received resveratrol supplements.Moreover,a statistically significant difference was detected in the mean change from baseline values of contrast sensitivity(0.17±0.19 vs 0.35±0.24,P=0.005),HADS Depression(0.08±1.38 vs-3.88±1.48,P<0.001),and HADS Anxiety(0.36±1.98 vs-5.12±2.70,P<0.001)scores,in favour of the patients treated with resveratrol supplements.CONCLUSION:The resveratrol oral supplement is a complementary treatment in cases of wet AMD,highlighting its effectiveness in improving patients’QoL status.
文摘目的观察无痛分娩联合音乐疗法对自然分娩产妇的影响。方法选择2022年1月至6月聊城市东昌府区妇幼保健院收治的88例拟行自然分娩的产妇进行随机对照试验。采用随机数字表法将其分为参照组与联合组,各44例。参照组年龄(30.56±1.06)岁,初产30例,次产14例,孕周(39.18±0.48)周;联合组年龄(30.75±1.13)岁,初产31例,次产13例,孕周(39.25±0.54)周。对照组采用传统分娩方法,联合组在参照组的基础上接受音乐疗法治疗。对比两组产妇视觉模拟量表(VAS)评分、医院焦虑抑郁量表(HADS)评分、治疗过程中不良事件、转剖宫产的人数。采用t检验和χ^(2)检验。结果两组产后12 h VAS评分均较产后2 h降低(均P<0.05),且联合组产后12 h VAS评分低于参照组(P<0.05)。干预前,两组HADS评分比较,差异无统计学意义(P>0.05);产后,两组HADS评分均低于干预前(均P<0.05),且联合组HADS评分低于参照组(P<0.05)。参照组不良事件发生率为9.09%(4/44),联合组为11.36%(5/44),差异无统计学意义(P>0.05)。结论无痛分娩联合音乐疗法有利于缓解自然分娩产妇疼痛,可改善产妇负性情绪,且安全可靠,值得推广。
文摘目的:在综合医院内科门诊病人中应用综合医院焦虑抑郁量表(Hospital Anxiety and Depres-sion Scale,HAD),并尝试建立上海地区常模。方法:采用两阶段抽样方法,首先在上海10余家综合医院中选取中山医院和瑞金医院内科门诊就诊人群,其次按10∶1比例在连续就诊序列中随机抽取11766例患者,采用HAD自评或辅助询问评估。结果:(1)内科门诊各年龄组病人在HAD焦虑均分(F=12.518,P<0.001)和抑郁均分(F=28.066,P<0.001)上差异显著,即随年龄递增焦虑评分有所降低,而抑郁评分则有所增高。(2)女性的HAD焦虑评分高于男性[(3.37±2.81)vs.(3.14±2.62),P<0.001],HAD抑郁评分在总样本中差异无统计学意义;但在60岁以下样本中,女性抑郁评分高于男性[(3.67±3.01)vs.(3.39±2.91),P=0.038],而在60～69岁年龄段,男性抑郁总均分高于女性[(5.63±3.86)vs.(4.86±3.70),P<0.001]。结论:综合医院焦虑抑郁量表在内科门诊病人应用过程中需注意年龄和性别因素的影响。
